• Home
  • EUCODIS Bioscience.

EUCODIS Bioscience.

About EUCODIS Bioscience.

EUCODIS Bioscience is an application-driven enzyme engineering and manufacturing company. We engineer enzymes using our proprietary gene shuffling and in-vivo recombination toolbox, which enables effective modification of target enzymes. We provide customized services in strain, bioprocess and DSP development as well as recombinant protein and enzyme production up to industrial-scale (under ISO 90...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • AT
  • 2015
    On CPHI since
Company types
Other
View company profile
Contact info
Show contact info Hide contact info

Products from EUCODIS Bioscience. (3)

  • Beta Lactamase Lacbuster - L

    Product Beta Lactamase Lacbuster - L

    Liquid, sterile, GMP-compliant formulation. A highly potent concentrate optimized for sterility testing. LacBuster L  is available as ready to use vials (10 ml) containing 2.500 IU beta lactamase I (Penicillinase) and 1.000 IU beta lactamase II (cephalosporinase), and bulk. 
  • Lipase Suicide Inhibitor: Butyl 4-nitrophenyl hexylphosphonate

    Product Lipase Suicide Inhibitor: Butyl 4-nitrophenyl hexylphosphonate

    EUCODIS lipase suicide inhibitors can be utilized to determine lipase and hydrolase activity, even in complex protein mixtures. The molar amount of enzyme can be determined by active site titration experiments. Chromogenic substrates for determination of active sites in lipases. Packaging: 10 mg.
  • Lipase CalB01 free/immobilised

    Product Lipase CalB01 free/immobilised

    Eucodis Bioscience offers a wide range of lipases like CalB01, either in free or immobilised from on different carriers. It belongs to lipases products category. Lipases/esterases can be used as versatile tools in hydrolytic reactions, esterifications and transesterification reactions  in industr...

EUCODIS Bioscience. Resources (1)

  • News SARS-CoV-2 Main Protease now available at EUCODIS

    We are proud to announce the addition of the SARS-CoV-2 main protease (SARS-CoV-2 Mpro) to our product portfolio. The SARS-CoV-2 Mpro enzyme was collaboratively developed by experts of EUCODIS and Biosynth Carbosynth for research purposes in Covid-19 diagnostics, drug development and for in vitro research on viral replication
    29 Sep 2021